Atopic dermatitis (eczema): open trials in Japan

8 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT06807281
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Fukuoka National Hospital, Fukuoka · Saruta Dermatology Clinic, Fukuoka · Dermatology and Ophthalmology Kume Clinic, Sakai · Sasamoto Children's Clinic, Setagaya-ku · Queen's square Medical Facilities Queen's square Dermatology and Allergology, Yokohama
Registry updated 2026-11-05
NCT07216027
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Trial Treatment · Phase 2 · Pfizer
Nihonbashi Sakura Clinic, Chuo-ku · Fukuwa Clinic, Chuo-ku · Kosugi Dermatology Clinic, Kawasaki-shi · Dermatology and Ophthalmology Kume Clinic, Sakai · Hattori Dermatology Clinic, Takasaki · Queen's square Medical Facilities Queen's square Dermatology and Allergology, Yokohama
Registry updated 2026-11-05
NCT05735483
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Trial Treatment · Phase 3 · Eli Lilly and Company
Asahikawa Medical College Hospital, Asahikawa · Fukuyama City Hospital, Fukuyama · Osaka Habikino Medical Center, Habikino · Hiroshima University Hospital, Hiroshima · Ina Central Hospital, Ina · Enomoto Clinic, Kumagaya · University Hospital Kyoto Prefectural University of Medicine, Kyoto · Okayama City General Medical Center Okayama City Hospital, Okayama · National Hospital Organization Sagamihara National Hospital, Sagamihara · Dermatology and Ophthalmology Kume Clinic, Sakai · Sugamo Sengoku Dermatology, Toshima City · Fujita Health University, Toyoake
Registry updated 2026-10-26
NCT07783425
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Nihonbashi Sakura Clinic, Chuo-ku · Fukuwa Clinic, Chuo-ku · Osaka Habikino Medical Center, Habikino · Katahira Dermatology Urology Clinic, Kagoshima · Japan Community Healthcare Organization Chukyo Hospital, Nagoya · Okayama University Hospital, Okayama · Pansy Skin Clinic, Saitama · Dermatology and Ophthalmology Kume Clinic, Sakai · Izumigaoka Skin Clinic, Sakai · Tachikawa Dermatology Clinic, Tachikawa · Ikebukuro-nishiguchi Fukurou Dermatology Clinic, Toshima-ku · Queen's Square Medical Facilities Queen's Square Medical Center, Dermatology and Allergology, Yokohama
Registry updated 2026-10-22
NCT07765888
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Charme Clinique, Matsudo · Miyata Dermatology Clinic, Matsudo · Aile Home Clinic Nagaoka, Nagaoka · Osaka Metropolitan University Hospital, Osaka · Dermatology and Ophthalmology Kume Clinic, Sakai · NTT Medical Center Tokyo, Shinagawa · Shibaki Dermatology Clinic, Teine-ku
Registry updated 2026-10-15
NCT06947993
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Fukuoka · Habikino · Kawasaki · Kyoto · Matsudo · Nagoya · Shinagawa Ku · Yokohama
Registry updated 2026-09-28
NCT06807268
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Saruta Dermatology Clinic, Fukuoka · Fukuoka National Hospital, Fukuoka · Dermatology and Ophthalmology Kume Clinic, Sakai · Sasamoto Children's Clinic, Setagaya-ku · Queen's square Medical Facilities Queen's square Dermatology and Allergology, Yokohama
Registry updated 2026-09-25
NCT07604324
A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis
Trial Treatment · Phase 1 · Novartis Pharmaceuticals
Fukuoka
Registry updated 2026-08-19

All Atopic dermatitis (eczema) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error